Balyasny Asset Management LLC Charles River Laboratories International, Inc. Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 434,226 shares of CRL stock, worth $77.8 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
434,226
Previous 52,794
722.49%
Holding current value
$77.8 Million
Previous $7.95 Million
729.16%
% of portfolio
0.11%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding CRL
# of Institutions
632Shares Held
52.8MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.04 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$911 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$675 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$390 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$333 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.11B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...